Man Group PLC Merck & Co., Inc. Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Man Group PLC holds 1,826,280 shares of MRK stock, worth $184 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

1,826,280

Previous 1,935,509 5.64%

Holding current value

$184 Million

Previous $240 Million 13.45%

% of portfolio

0.58%

Previous 0.64%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $12.1 Million - $14.1 Million	-109,229 Reduced 5.64%	1,826,280 $207 Million
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $2.37 Million - $2.54 Million	-19,114 Reduced 0.98%	1,935,509 $240 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $120 Million - $140 Million	1,060,236 Added 118.54%	1,954,623 $258 Million
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $68.5 Million - $74.5 Million	683,710 Added 324.53%	894,387 $97.5 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $1.53 Million - $1.7 Million	-14,907 Reduced 6.61%	210,677 $21.7 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $4.27 Million - $4.65 Million	-39,317 Reduced 14.84%	225,584 $26 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $55.4 Million - $61.8 Million	-538,117 Reduced 67.01%	264,901 $28.2 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $2 Million - $2.57 Million	22,898 Added 2.94%	803,018 $89.1 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $54,944 - $61,723	650 Added 0.08%	780,120 $67.2 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $28.2 Million - $32 Million	-338,175 Reduced 30.26%	779,470 $71.1 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $58 Million - $65 Million	-788,523 Reduced 41.37%	1,117,645 $91.7 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $70.7 Million - $88.6 Million	978,320 Added 105.44%	1,906,168 $146 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $89.5 Million - $98.4 Million	-1,247,958 Reduced 57.36%	927,848 $69.7 Million
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $84.2 Million - $93.2 Million	-1,198,100 Reduced 35.51%	2,175,806 $169 Million
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $111 Million - $131 Million	1,616,871 Added 92.02%	3,373,906 $260 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $20 Million - $22.2 Million	278,568 Added 18.84%	1,757,035 $144 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $5.15 Million - $5.84 Million	70,405 Added 5.0%	1,478,467 $123 Million
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $43.4 Million - $49.4 Million	-615,909 Reduced 30.43%	1,408,062 $109 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $62.6 Million - $86.8 Million	988,086 Added 95.39%	2,023,971 $156 Million
Q4 2019 Feb 18, 2020	BUY	$77.58 - $87.54 $68.1 Million - $76.8 Million	877,489 Added 553.98%	1,035,885 $94.2 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $10.9 Million - $11.9 Million	-143,151 Reduced 47.47%	158,396 $13.3 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $221,113 - $258,313	3,166 Added 1.06%	301,547 $25.3 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $4.34 Million - $4.95 Million	-62,341 Reduced 17.28%	298,381 $24.8 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $3.47 Million - $4.02 Million	-53,146 Reduced 12.84%	360,722 $27.6 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $4.82 Million - $5.67 Million	83,534 Added 25.29%	413,868 $29.4 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $892,015 - $1.05 Million	17,549 Added 5.61%	330,334 $20.1 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $15.9 Million - $18.5 Million	312,785 New	312,785 $17 Million

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $255B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account